Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer
about
RhoA as a mediator of clinically relevant androgen action in prostate cancer cellsThe LIM-only protein FHL2 mediates ras-induced transformation through cyclin D1 and p53 pathways.SLR-2 and JMJC-1 regulate an evolutionarily conserved stress-response network.Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.Identification of a clinically relevant androgen-dependent gene signature in prostate cancerLinking actin dynamics and gene transcription to drive cellular motile functions.Androgen modulation of coregulator expression in prostate cancer cells.Epigenetic regulation of androgen receptor signaling in prostate cancer.Identification of gene co-expression clusters in liver tissues from multiple porcine populations with high and low backfat androstenone phenotype.The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation.Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action.Androgen-responsive serum response factor target genes regulate prostate cancer cell migration.Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approachAndrogen receptor co-activators in the regulation of cellular events in prostate cancer.The role of transcription factors in prostate cancer and potential for future RNA interference therapy.Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?Gene interference strategies as a new tool for the treatment of prostate cancer.Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.The FHL2 regulation in the transcriptional circuitry of human cancers.Relationship between serum response factor and androgen receptor in prostate cancer.Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases.FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.Differential regulation of steroid nuclear receptor coregulator expression between normal and neoplastic prostate epithelial cells.FHL2 interacts with iASPP and impacts the biological functions of leukemia cells.A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer.
P2860
Q24618899-65039378-A6D9-4118-B175-AA3CE281483BQ33385456-2665C093-9EFB-4756-8F03-4E3C98F152ADQ33690581-A8418317-E02C-475E-9DC7-8A3097B212CEQ33775717-C70DCD86-774D-4818-827A-B3748DF4E5C3Q33815903-37487242-9E05-4BD8-AA2E-726F0159DFD5Q33821752-091D9BB7-7108-4365-BB73-6D6988263BCCQ34111717-AC29CCDD-A368-47D8-ACC4-4C44C7FFA871Q34928162-D5D09522-352D-4AD2-84AD-A9746853EF93Q35148259-E40F387F-40FC-4268-9436-C316F15D09FAQ35195263-B4824270-EC5C-4789-B6D8-0D3FB485A31DQ36294460-C9A4B81A-1C5F-468D-996D-640664394757Q36578330-5FDABC86-3A7A-4966-9522-C90B346BBB3DQ37065350-026B6EFB-0A96-4F69-8EB2-F6B1D6E33B26Q37145531-2BC45785-054A-4E39-8A58-3EBF82DFB42BQ37151504-168E79E0-64D4-4AB0-8D7E-DDC5449F4CE3Q37237411-E942F9A8-A065-45BC-8E4D-46B375A05329Q37959244-20F5FE0C-82B6-4D02-9328-BA8F8A0403F6Q38198726-89F55E51-87CD-485E-839A-DB1DC4600143Q38318104-FF834B34-C2CB-4A6D-9EBF-CCE6CF2ADA90Q38518046-FAD68789-9989-4107-8C8B-3F22074B8800Q38552283-8B31FD30-1E1C-4837-9DE5-D6B979E27F09Q38554494-D51C64A8-D311-4F04-9349-99ADB5A1077DQ38845729-0622DE63-C66D-4385-AC6C-90539B608A55Q38871314-7F82AD46-C55A-483D-9161-8C515A105DE2Q39312424-40044A2C-EBAE-4F3C-8274-3B0D79866B2CQ39534119-BD32B4F0-00C6-458C-B2E3-3F2D671EAE71Q39737903-78CDE471-F5CF-43AC-ACCB-2A957E481994Q41092432-D0EBD213-9D6A-4352-8D96-2FF8A84CFA15Q41691950-D6A212C7-5863-4FCF-9EDC-E04715EC4749
P2860
Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Androgen induction of the andr ...... onse factor in prostate cancer
@ast
Androgen induction of the andr ...... onse factor in prostate cancer
@en
Androgen induction of the andr ...... onse factor in prostate cancer
@en-gb
Androgen induction of the andr ...... onse factor in prostate cancer
@nl
type
label
Androgen induction of the andr ...... onse factor in prostate cancer
@ast
Androgen induction of the andr ...... onse factor in prostate cancer
@en
Androgen induction of the andr ...... onse factor in prostate cancer
@en-gb
Androgen induction of the andr ...... onse factor in prostate cancer
@nl
prefLabel
Androgen induction of the andr ...... onse factor in prostate cancer
@ast
Androgen induction of the andr ...... onse factor in prostate cancer
@en
Androgen induction of the andr ...... onse factor in prostate cancer
@en-gb
Androgen induction of the andr ...... onse factor in prostate cancer
@nl
P2093
P921
P3181
P1433
P1476
Androgen induction of the andr ...... onse factor in prostate cancer
@en
P2093
Donald J Tindall
Hannelore V Heemers
Kevin M Regan
Scott M Dehm
P304
P3181
P356
10.1158/0008-5472.CAN-07-1917
P407
P577
2007-11-01T00:00:00Z